Insights
Notes on safer medicine access
Stories, explainers, and field notes from Nigeria's pharmaceutical supply chain.
2026-04-22
Why escrow matters when you buy medicine online in Nigeria
Counterfeits, no-shows, and ghost vendors have made online medicine risky. Here's how escrow flips the trust model.
Read article2026-03-10
NAFDAC vs PCN: who regulates what in Nigerian pharmacy
If you've ever wondered which regulator governs the medicine and which governs the pharmacy, this is your map.
Read article2026-02-05
The Amber Shelf: helping rare and short-dated medicines find patients
Short-dated stock and rare medications shouldn't be wasted — or weaponised. Here's how MedOasis routes them safely.
Read article2026-05-02
How to spot a fake online pharmacy in Nigeria (a 7-point checklist)
Bank transfers vanish, WhatsApp numbers go silent, blister packs arrive blank. Here's the buyer-side checklist we use at MedOasis.
Read article2026-04-18
Escrow vs pay-on-delivery: which actually protects medicine buyers in Nigeria?
POD feels safe until the rider leaves. Here's why escrow is the only model that protects both sides of a Nigerian medicine transaction.
Read article2026-04-04
Buying medicine in Lagos vs rural Nigeria: the access gap nobody talks about
A patient in Ikoyi and a patient in Bauchi shouldn't have wildly different odds of getting genuine medicine. Today they do.
Read article2026-03-22
NDPR and your medicine data: what Nigerian buyers should expect from a health marketplace
Your prescription history is health data. Here's what the Nigeria Data Protection Act requires — and what we do at MedOasis.
Read article2026-03-08
Inside MedOasis vendor onboarding: how a pharmacy becomes verified
Verification isn't a badge — it's a process. Here's exactly what a Nigerian pharmacy goes through to list on MedOasis.
Read article